Published in J Gen Virol on May 01, 2006
Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses (2011) 1.14
Molecular and immunological tools for the evaluation of the cellular immune response in the neotropical monkey Saimiri sciureus, a non-human primate model for malaria research. Malar J (2015) 0.87
Dynamic interaction between STLV-1 proviral load and T-cell response during chronic infection and after immunosuppression in non-human primates. PLoS One (2009) 0.83
Early-life exposures to infectious agents and later cancer development. Cancer Med (2015) 0.82
Splenic architecture disruption and parasite-induced splenocyte activation and anergy in Plasmodium falciparum-infected Saimiri sciureus monkeys. Malar J (2015) 0.80
Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals. Virol J (2013) 0.77
Endemic Viruses of Squirrel Monkeys (Saimiri spp.). Comp Med (2015) 0.75
Characterization of reemerging chikungunya virus. PLoS Pathog (2007) 3.22
Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One (2007) 2.47
Sentinel surveillance system for early outbreak detection in Madagascar. BMC Public Health (2010) 2.36
Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol (2010) 2.27
Inferring the demographic history of African farmers and pygmy hunter-gatherers using a multilocus resequencing data set. PLoS Genet (2009) 2.07
Origins and genetic diversity of pygmy hunter-gatherers from Western Central Africa. Curr Biol (2009) 2.01
Maternal traces of deep common ancestry and asymmetric gene flow between Pygmy hunter-gatherers and Bantu-speaking farmers. Proc Natl Acad Sci U S A (2008) 1.96
Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med (2009) 1.92
Smallpox vaccine safety is dependent on T cells and not B cells. J Infect Dis (2011) 1.86
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP. Blood (2010) 1.77
Influenza surveillance in 15 countries in Africa, 2006-2010. J Infect Dis (2012) 1.76
Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis. Ann Neurol (2009) 1.75
Serological and molecular evidence that human herpesvirus 8 is endemic among Amerindians in French Guiana. J Infect Dis (2005) 1.74
Short message service sentinel surveillance of influenza-like illness in Madagascar, 2008-2012. Bull World Health Organ (2012) 1.72
Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology (2005) 1.70
Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol (2008) 1.69
Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. J Natl Cancer Inst (2007) 1.68
Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. J Cell Sci (2004) 1.67
Human T lymphotropic virus type 1 subtype C melanesian genetic variants of the Vanuatu Archipelago and Solomon Islands share a common ancestor. J Infect Dis (2007) 1.66
Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease. Blood (2008) 1.53
Restriction of foamy viruses by APOBEC cytidine deaminases. J Virol (2006) 1.52
High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis (2003) 1.51
Mono/oligoclonal pattern of Kaposi Sarcoma-associated herpesvirus (KSHV/HHV-8) episomes in primary effusion lymphoma cells. Int J Cancer (2005) 1.48
Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest (2005) 1.46
CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood (2006) 1.45
Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology (2008) 1.45
Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis. Arch Neurol (2009) 1.42
The linkage disequilibrium maps of three human chromosomes across four populations reflect their demographic history and a common underlying recombination pattern. Genome Res (2005) 1.40
Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa. PLoS Pathog (2011) 1.39
Viral etiology of influenza-like illnesses in Antananarivo, Madagascar, July 2008 to June 2009. PLoS One (2011) 1.38
A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 tax protein sequences is responsible for their divergent subcellular distribution. J Biol Chem (2004) 1.37
Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol (2002) 1.35
Simian foamy virus transmission from apes to humans, rural Cameroon. Emerg Infect Dis (2007) 1.35
Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation. Blood (2006) 1.33
Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33
Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med (2007) 1.32
Quiescent phenotype of tumor-specific CD8+ T cells following immunization. Blood (2004) 1.29
HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165. Blood (2009) 1.27
Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J Virol (2006) 1.26
Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol (2007) 1.26
Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog (2006) 1.24
HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. J Pediatr (2004) 1.23
Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection. J Infect Dis (2006) 1.22
Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations. J Neurovirol (2014) 1.22
Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother (2002) 1.19
Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. Blood (2011) 1.18
HTLV-1 and associated adult T-cell leukemia/lymphoma. Rev Clin Exp Hematol (2003) 1.18
A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology (2009) 1.18
Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physiol (2002) 1.17
Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding. J Virol (2004) 1.17
Application of broad-spectrum resequencing microarray for genotyping rhabdoviruses. J Virol (2010) 1.16
Molecular characterization of three Zika flaviviruses obtained from sylvatic mosquitoes in the Central African Republic. Vector Borne Zoonotic Dis (2014) 1.15
Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder. PLoS One (2009) 1.15
Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res (2002) 1.15
Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein. J Biol Chem (2008) 1.14
Modes of transmission and genetic diversity of foamy viruses in a Macaca tonkeana colony. Retrovirology (2006) 1.14
Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med (2013) 1.14
Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes. J Neurovirol (2005) 1.12
Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J Infect Dis (2006) 1.12
Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein. J Virol (2006) 1.11
Neuroimmunity of HTLV-I Infection. J Neuroimmune Pharmacol (2010) 1.11
Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease. Herpes (2005) 1.11
Human herpes virus 6B: a possible role in epilepsy? Epilepsia (2008) 1.10
Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum Mol Genet (2006) 1.09
Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans. Infect Immun (2006) 1.09
Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J Virol (2006) 1.09
Divergent simian T-cell lymphotropic virus type 3 (STLV-3) in wild-caught Papio hamadryas papio from Senegal: widespread distribution of STLV-3 in Africa. J Virol (2003) 1.09
In vivo quantification of T₂ anisotropy in white matter fibers in marmoset monkeys. Neuroimage (2011) 1.08
Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice. J Virol (2008) 1.08
Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease. Blood (2008) 1.07
GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1. J Virol (2006) 1.07
Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings. J Clin Virol (2013) 1.06
High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol (2003) 1.06
Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections. Nat Med (2003) 1.06
Review part 2: Human herpesvirus-6 in central nervous system diseases. J Med Virol (2010) 1.05
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood (2010) 1.05
Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease. Ann Neurol (2005) 1.05
New strain of human T lymphotropic virus (HTLV) type 3 in a Pygmy from Cameroon with peculiar HTLV serologic results. J Infect Dis (2009) 1.05
Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients. PLoS One (2008) 1.05
High-density resequencing DNA microarrays in public health emergencies. Nat Biotechnol (2010) 1.04
HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. J Clin Invest (2006) 1.03
Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis. J Neurovirol (2005) 1.03
Translocator protein PET imaging for glial activation in multiple sclerosis. J Neuroimmune Pharmacol (2010) 1.03
The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol Biol (Paris) (2008) 1.02
Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology. Ann Epidemiol (2010) 1.02
HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects. Viruses (2011) 1.02
Human T cell leukemia virus type 2 tax-mediated NF-κB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO. J Virol (2012) 1.01
Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome. Blood (2010) 1.01
Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy. Neurol Clin (2008) 1.01
Hepatitis B and C virus infections in the three Pygmy groups in Cameroon. J Clin Microbiol (2010) 1.00
Litchi-associated acute encephalitis in children, Northern Vietnam, 2004-2009. Emerg Infect Dis (2012) 1.00
Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging. Mult Scler (2013) 1.00
Low nuclear body formation and tax SUMOylation do not prevent NF-kappaB promoter activation. Retrovirology (2012) 1.00
Natural simian foamy virus infection in wild-caught gorillas, mandrills and drills from Cameroon and Gabon. J Gen Virol (2004) 1.00